Last update 11 May 2025

US20240101559

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
CDK11B x JAK x JAK2
Action
inhibitors
Mechanism
CDK inhibitors(Cyclin-dependent kinase inhibitors), CDK11B inhibitors(cyclin dependent kinase 11B inhibitors), CDK19 inhibitors(Cyclin-dependent kinase 19 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesInfectious Diseases+ [3]
Active Indication
Alzheimer DiseaseDermatophilosisImmune System Diseases+ [3]
Inactive Indication-
Originator Organization
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
Active Organization
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with US20240101559
Login to view more data
100 Translational Medicine associated with US20240101559
Login to view more data
100 Patents (Medical) associated with US20240101559
Login to view more data
100 Deals associated with US20240101559
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Alzheimer DiseaseDiscovery-
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
28 Mar 2024
DermatophilosisDiscovery-
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
28 Mar 2024
Immune System DiseasesDiscovery-
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
28 Mar 2024
Myeloproliferative DisordersDiscovery-
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
28 Mar 2024
NeoplasmsDiscovery-
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
28 Mar 2024
Neovascularization, PathologicDiscovery-
Dana-Farber Cancer Institute, Inc.Dana-Farber Cancer Institute, Inc.
28 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free